These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
297 related articles for article (PubMed ID: 26002052)
1. Efficacy of Glutamate Modulators in Tic Suppression: A Double-Blind, Randomized Control Trial of D-serine and Riluzole in Tourette Syndrome. Lemmon ME; Grados M; Kline T; Thompson CB; Ali SF; Singer HS Pediatr Neurol; 2015 Jun; 52(6):629-34. PubMed ID: 26002052 [TBL] [Abstract][Full Text] [Related]
2. Ecopipam, a D1 receptor antagonist, for treatment of tourette syndrome in children: A randomized, placebo-controlled crossover study. Gilbert DL; Murphy TK; Jankovic J; Budman CL; Black KJ; Kurlan RM; Coffman KA; McCracken JT; Juncos J; Grant JE; Chipkin RE Mov Disord; 2018 Aug; 33(8):1272-1280. PubMed ID: 30192018 [TBL] [Abstract][Full Text] [Related]
3. Double-blind, crossover study of clonidine and levetiracetam in Tourette syndrome. Hedderick EF; Morris CM; Singer HS Pediatr Neurol; 2009 Jun; 40(6):420-5. PubMed ID: 19433274 [TBL] [Abstract][Full Text] [Related]
4. Efficacy and Safety of Fixed-Dose Deutetrabenazine in Children and Adolescents for Tics Associated With Tourette Syndrome: A Randomized Clinical Trial. Coffey B; Jankovic J; Claassen DO; Jimenez-Shahed J; Gertz BJ; Garofalo EA; Stamler DA; Wieman M; Savola JM; Gordon MF; Alexander JK; Barkay H; Harary E JAMA Netw Open; 2021 Oct; 4(10):e2129397. PubMed ID: 34661664 [TBL] [Abstract][Full Text] [Related]
5. A double blind randomized placebo control trial of levetiracetam in Tourette syndrome. Smith-Hicks CL; Bridges DD; Paynter NP; Singer HS Mov Disord; 2007 Sep; 22(12):1764-70. PubMed ID: 17566124 [TBL] [Abstract][Full Text] [Related]
6. A placebo-controlled trial of risperidone in Tourette syndrome. Scahill L; Leckman JF; Schultz RT; Katsovich L; Peterson BS Neurology; 2003 Apr; 60(7):1130-5. PubMed ID: 12682319 [TBL] [Abstract][Full Text] [Related]
7. Safety and Efficacy of Flexible-Dose Deutetrabenazine in Children and Adolescents With Tourette Syndrome: A Randomized Clinical Trial. Jankovic J; Coffey B; Claassen DO; Jimenez-Shahed J; Gertz BJ; Garofalo EA; Stamler DA; Wieman M; Savola JM; Gordon MF; Alexander J; Barkay H; Harary E JAMA Netw Open; 2021 Oct; 4(10):e2128204. PubMed ID: 34609495 [TBL] [Abstract][Full Text] [Related]
9. Baclofen treatment in Tourette syndrome: a double-blind, placebo-controlled, crossover trial. Singer HS; Wendlandt J; Krieger M; Giuliano J Neurology; 2001 Mar; 56(5):599-604. PubMed ID: 11245709 [TBL] [Abstract][Full Text] [Related]
10. A randomized, double-blind, placebo-controlled trial of metoclopramide for the treatment of Tourette's disorder. Nicolson R; Craven-Thuss B; Smith J; McKinlay BD; Castellanos FX J Am Acad Child Adolesc Psychiatry; 2005 Jul; 44(7):640-6. PubMed ID: 15968232 [TBL] [Abstract][Full Text] [Related]
13. A randomised, double-blind, placebo-controlled study of topiramate in the treatment of Tourette syndrome. Jankovic J; Jimenez-Shahed J; Brown LW J Neurol Neurosurg Psychiatry; 2010 Jan; 81(1):70-3. PubMed ID: 19726418 [TBL] [Abstract][Full Text] [Related]
14. Effectiveness and tolerability of aripiprazole in children and adolescents with Tourette's disorder: a pilot study in China. Cui YH; Zheng Y; Yang YP; Liu J; Li J J Child Adolesc Psychopharmacol; 2010 Aug; 20(4):291-8. PubMed ID: 20807067 [TBL] [Abstract][Full Text] [Related]
15. Delta 9-tetrahydrocannabinol (THC) is effective in the treatment of tics in Tourette syndrome: a 6-week randomized trial. Müller-Vahl KR; Schneider U; Prevedel H; Theloe K; Kolbe H; Daldrup T; Emrich HM J Clin Psychiatry; 2003 Apr; 64(4):459-65. PubMed ID: 12716250 [TBL] [Abstract][Full Text] [Related]
16. The treatment of attention-deficit hyperactivity disorder in Tourette's syndrome: a double-blind placebo-controlled study with clonidine and desipramine. Singer HS; Brown J; Quaskey S; Rosenberg LA; Mellits ED; Denckla MB Pediatrics; 1995 Jan; 95(1):74-81. PubMed ID: 7770313 [TBL] [Abstract][Full Text] [Related]
17. Randomized, Double-Blind, Placebo-Controlled Trial Demonstrates the Efficacy and Safety of Oral Aripiprazole for the Treatment of Tourette's Disorder in Children and Adolescents. Sallee F; Kohegyi E; Zhao J; McQuade R; Cox K; Sanchez R; van Beek A; Nyilas M; Carson W; Kurlan R J Child Adolesc Psychopharmacol; 2017 Nov; 27(9):771-781. PubMed ID: 28686474 [TBL] [Abstract][Full Text] [Related]
18. A double-blind, sham-controlled, trial of home-administered rhythmic 10-Hz median nerve stimulation for the reduction of tics, and suppression of the urge-to-tic, in individuals with Tourette syndrome and chronic tic disorder. Maiquez BM; Smith C; Dyke K; Chou CP; Kasbia B; McCready C; Wright H; Jackson JK; Farr I; Badinger E; Jackson GM; Jackson SR J Neuropsychol; 2023 Sep; 17(3):540-563. PubMed ID: 37133932 [TBL] [Abstract][Full Text] [Related]
19. Randomized double-blind multicentre placebo-controlled clinical trial of the clonidine adhesive patch for the treatment of tic disorders. Du YS; Li HF; Vance A; Zhong YQ; Jiao FY; Wang HM; Wang MJ; Su LY; Yu DL; Ma SW; Wu JB Aust N Z J Psychiatry; 2008 Sep; 42(9):807-13. PubMed ID: 18696285 [TBL] [Abstract][Full Text] [Related]
20. Short-term sulpiride treatment of children and adolescents with Tourette syndrome or chronic tic disorder. Ho CS; Chen HJ; Chiu NC; Shen EY; Lue HC J Formos Med Assoc; 2009 Oct; 108(10):788-93. PubMed ID: 19864199 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]